申请人:SMITHKLINE BECKMAN CORPORATION
公开号:EP0285356A2
公开(公告)日:1988-10-05
Compounds of formula (I)
in which X is H, F, Cl, Br, I, C₁₋₄alkyl, CN, NO₂, SO₂NH₂, COOH, CHO, C₁₋₄alkoxy, CH₂OH, CF₃, SO₂CH₃, SO₂CF₃ or CO₂CaH2a+1 wherein a is 1-5, or any accessible combination thereof of up to 3 substituents; R is H or C₁₋₄alkyl; and n is 1-5; or any pharmaceutically acceptable salt or hydrate thereof, processes for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them and their use in therapy as dopamine-β-hydroxylase inhibitors.
式 (I) 的化合物
其中 X 是 H、F、Cl、Br、I、C₁₋₄alkyl、CN、NO₂、SO₂NH₂、COOH、CHO、C₁₋₄alkoxy、CH₂OH、CF₃、SO₂CH₃、SO₂CF₃ 或 CO₂CaH2a+1(其中 a 为 1-5),或其中最多 3 个取代基的任何可获得的组合;R 是 H 或 C₁₋₄ 烷基;或其任何药学上可接受的盐或水合物、其制备工艺、用于制备它们的中间体、含有它们的药物组合物以及它们作为多巴胺-β-羟化酶抑制剂在治疗中的用途。